| Document Date: 2012-05-01 15:27:16
Open Document File Size: 43,02 KBShare Result on Facebook
Company Stiefel Laboratories Inc. / GSK Group / GLAXOSMITHKLINE PLC / / Country Japan / Russia / Brazil / China / India / / Currency USD / / Event M&A / Company Expansion / Business Partnership / Reorganization / / IndustryTerm prescription dermatology products / prescription dermatological products / over-the-counter and aesthetic products / research-based pharmaceutical / experienced management / marketed dermatology products / skin health solutions / formulation technologies / manufacturing / dermatology products / healthcare / manufacturing capability / manufacturing plants / / Person Charles W. Stiefel / Andrew Witty / / / Position specialist global business / Chairman and Chief Executive Officer / Chief Executive Officer / CEO and Chairman of the Board / / Product Cutivate / Duac / Altabax / Olux E / Bactroban / Soriatane / / Technology formulation technologies / / URL www.stiefel.com / www.gsk.com / /
SocialTag |
Microsoft Word - Press Release Stiefel - April 20, 2009